Unlock Key Insights for Success in Advanced Therapies
Explore comprehensive reports with exclusive data and expert analysis to guide your decisions in PSC-derived therapies.
Get your report today!
A detailed evaluation of leading GMP hPSC providers, with insights on quality standards, regulatory compliance, and manufacturing capabilities. This to make sure you choose the right vendors to optimize your supply chain, avoid costly mistakes, and meet the highest industry standards.
Comprehensive expert report covering key competitors, emerging technologies, and trends in reprogramming methods, helping you make informed decisions. This, to help you navigate the global patent landscape and adapt your go-to-market strategy.
Values for Decision Makers -
Values for Decision Makers -
In a rapidly evolving field of advanced therapies, making informed decisions is crucial for maintaining a competitive edge. Our reports provide decision-makers with the strategic intelligence needed to navigate complex landscapes, from intellectual property to GMP-compliant start material providers.
Scroll to learn how our Reports can benefit You ↓
EXPERT REPORTS
Global Analysis of GMP hPSC Start Material
In the fast-growing field of PSC-derived cell therapies, choosing the right starting materials is critical to success. Our comprehensive evaluation of GMP hPSC lines offers a clear path forward, providing actionable insights into derivation technologies, IP, donor eligibility, and regulatory standards. With over 26 hiPSC lines analyzed, this report highlights the best options for clinical and commercial development. It is designed to help you avoid costly mistakes and accelerate the development of innovative hPSC-based therapies.
Global iPSC Patent Landscape Analysis
This patent landscape analysis offers a comprehensive overview of the technological trends in iPSC production, focusing on reprogramming factors, delivery methods, and source cell types. It provides key insights for making informed strategic decisions in the competitive field of iPSC technology. The report identifies leading players and maps the patent environment, helping businesses understand the state of the art and plan their next steps in this rapidly evolving sector.
Exclusive Consultation Included
Each report purchase includes 1.5 hours of one-on-one consulting with the authors. This personalized session allows you to explore the report’s findings, ask specific questions, and receive tailored guidance to implement insights directly into your projects.
Purchase Now and Book Your Consultation
KEY VALUES
Strategic Insight
Gain a deep understanding of the IP landscape and vendor ecosystem to identify opportunities, avoid pitfalls, and make data-driven decisions that align with your company’s strategic goals.
Risk Mitigation
Our analyses help de-risk your projects by identifying potential IP conflicts, regulatory challenges, and supplier vulnerabilities, allowing you to proactively address these issues.
Optimized Vendor Selection
Make better choices by accessing comprehensive evaluations of GMP hPSC start material providers, ensuring your supply chain is robust, compliant, and scalable.
BENEFITS
Time/Cost Efficiency
Identify cost-saving opportunities through vendor comparisons and IP strategies that prevent unnecessary litigation or delays. Further, save time by having us do the vendor outreach and due dilligence.
Accelerated Development
Reduce time to market by leveraging insights that streamline decision-making and optimize operational strategies.
Enhanced Compliance
Stay ahead of regulatory changes and ensure your processes align with industry standards, supporting smoother approvals.
By integrating our expert-driven reports into your decision-making process, you can confidently advance your projects, secure your market position, and maximize your progress.
What Clients Are Saying
HOYA Consulting's IP Landscape Analysis provided us with essential insights into the Advanced Therapy sector. It enabled us to navigate potential IP risks while uncovering significant opportunities. The report simplified a complex process, and collaborating with the team was a truly positive experience.
Commercial Director
CDMO
Meet the authors
Heather Main - Cofounder and Principal Consultant
Ajdin Jakupovic - Cofounder and Managing Partner
Anna Falk - Cofounder and Subject Matter Expert
FAQs
-
Each report provides comprehensive insights tailored to support decision-making in PSC-derived cell therapies. The Global GMP Lines Analysis report includes evaluations of key GMP hPSC providers, covering quality standards, regulatory compliance, and manufacturing capabilities. The hiPSC IP Landscape Analysis report offers an in-depth view of the patent landscape, highlighting key competitors, emerging technologies, and IP trends that can guide your strategic planning.
-
Once your purchase is complete, our team will reach out to coordinate a time for the 1.5-hour consultation with the authors. This meeting can be scheduled at a time that suits your needs and will provide an opportunity to dive deeper into the report findings, answer any specific questions, and receive tailored guidance for your projects.
-
After completing your purchase and receiving any necessary vendor approvals, you’ll receive a digital copy of the report directly via email. Our team will also contact you to arrange the included 1.5-hour consultation with the report authors, where we can discuss the findings and answer your questions in depth.
-
Yes, our reports are intended for individual or organizational use by the purchaser only. Unauthorized sharing, distribution, or resale of the report is prohibited. By purchasing, you agree to use the report solely within your organization and not to distribute it externally without prior permission from HOYA Consulting.
Get in touch.
Have questions about our reports or want to explore how our insights can support your projects? Or are you still not convinced and want a teaser? No matter, we’d love to hear from you! Fill out the form below, and our team will get back to you promptly. Let’s connect and discuss how we can drive your advanced therapy development forward.
HOYA - ABOUT
HOYA - ABOUT
HOYA is your strategic partner in advanced therapy, with deep expertise in pluripotent-derived cell therapies. We help our clients de-risk complex preclinical and commercial challenges, accelerating early research to broad patient access. Leveraging our extensive global network and tailoring solutions to each client’s unique needs, we help drive innovation forward.
Our Services
-
With deep knowledge of hPSC, we offer the hands-on technical expertise needed to advance your research from lab to clinic, ensuring the highest quality and compliance throughout the process.
-
We provide a roadmap for GMP compliance, ensuring your cell therapy products are manufactured with the highest standards of quality.
-
Our strong relationships with leading academic institutions, biotech companies, and industry regulators give you access to a powerful network that can accelerate the development of your therapies.
Advanced Therapy Translation
-
From concept to clinical trials, we guide the entire product development process for hPSC-derived therapies, focusing on the regulatory, technical, and commercial aspects. Our team is well-versed in overcoming the hurdles of product validation and GMP operations.
-
We connect academia with industry leaders to foster collaborations that push the boundaries of cell therapy innovation. By leveraging our extensive network of industrial partners, we help accelerate research into practical, market-ready solutions.
-
Navigating the transition from research to GMP manufacturing can be challenging. We provide pre-GMP support to ensure your processes, materials, and protocols are aligned with regulatory expectations, minimizing delays and ensuring smooth progression to full-scale production.
Research and Development
Finance and Growth
-
Stay ahead of the competition with our in-depth market analysis. We provide actionable insights into emerging trends, competitor activities, and market demands within the cell therapy landscape, empowering you to make informed business decisions.
-
Whether you're at the initial stages of development or looking to commercialize, we offer strategic guidance tailored to your specific needs. Our expertise covers regulatory pathways, product lifecycle management, and commercialization strategies to ensure your cell therapies succeed.
-
We help you identify and secure grant funding to propel your cell therapy projects forward. Our knowledge of funding programs and the right partners will assist in writing and submitting grants in a timely and efficient manner.